Acute Hypoattenuating Leaflet Thickening after Percutaneous Pulmonary Valve Implantation: A Case Report
Structural and Congenital Heart Disease · 2026
DOI: 10.32604/schd.2026.078486 ↗Kurz gefasst
Fallbericht in der Zeitschrift Structural and Congenital Heart Disease, 2026. Verfasst von Yee-Tat Lee und 7 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Hypoattenuating leaflet thickening (HALT) is a reported complication following percutaneous pulmonary valve implantation (PPVI) Case description: A 32-year-old man with a history of repaired Tetralogy of Fallot (TOF) underwent PPVI for symptomatic severe pulmonary regurgitation (PR). The postoperative course was complicated by HALT diagnosed by computed tomography (CT) within 24 h of the procedure. Anticoagulation therapy was administered, and reassessment CT at 4 months showed resolution of HALT.
Conclusion
HALT following PPVI is managed with anticoagulation yet consensus for optimal management strategy is lacking.
Zitieren
APA
Lee, Y., Chen, H. R., Leung, K. C., Wong, C., Chiu, H. A., Cheung, C. S., Mak, Y., & Un, K. (2026). Acute Hypoattenuating Leaflet Thickening after Percutaneous Pulmonary Valve Implantation: A Case Report. Structural and Congenital Heart Disease. https://doi.org/10.32604/schd.2026.078486
Vancouver
Lee Y, Chen HR, Leung KC, Wong C, Chiu HA, Cheung CS, et al. Acute Hypoattenuating Leaflet Thickening after Percutaneous Pulmonary Valve Implantation: A Case Report. Structural and Congenital Heart Disease. 2026. doi:10.32604/schd.2026.078486
BibTeX
@article{Lee2026,
author = {Lee, Yee-Tat and Chen, Hay-Son Robin and Leung, Ka-Lam Calvin and Wong, Chun-Ka and Chiu, Ho-On Alston and Cheung, Chi-Wai Stephen and Mak, Yuen-Hei and Un, Ka-Chun},
title = {Acute Hypoattenuating Leaflet Thickening after Percutaneous Pulmonary Valve Implantation: A Case Report},
journal = {Structural and Congenital Heart Disease},
year = {2026},
doi = {10.32604/schd.2026.078486}
}
EUVIMED